Nature Communications (May 2019)

Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs

  • Kale Kundert,
  • James E. Lucas,
  • Kyle E. Watters,
  • Christof Fellmann,
  • Andrew H. Ng,
  • Benjamin M. Heineike,
  • Christina M. Fitzsimmons,
  • Benjamin L. Oakes,
  • Jiuxin Qu,
  • Neha Prasad,
  • Oren S. Rosenberg,
  • David F. Savage,
  • Hana El-Samad,
  • Jennifer A. Doudna,
  • Tanja Kortemme

DOI
https://doi.org/10.1038/s41467-019-09985-2
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 11

Abstract

Read online

Control of CRISPR-Cas9 activity allows for fine-tuning of editing and gene expression. Here the authors use gRNAs modified with RNA aptamers to enable small molecule control in bacterial systems.